Furthermore, genes in our model such as MUC5B and TREM1 have been documented in relevant literature for their roles in the tumor immune microenvironment and prognosis[46,47], underscoring the model’s multidimensional novelty and clinical applicability. The gene discussed is MUC5B; the disease is neoplasm.